Drug Type Enzyme |
Synonyms GILT-recombinant-human-acid-alfa-glucosidase, GILT-rhGAA, GILT-tagged recombinant human GAA + [6] |
Target |
Action stimulants |
Mechanism α-glucosidase stimulants(Acidic alpha-glucosidase stimulants) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
RegulationOrphan Drug (United States) |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Glycogen Storage Disease Type II | Phase 3 | United States | 01 Apr 2014 | |
| Glycogen Storage Disease Type II | Phase 3 | Belgium | 01 Apr 2014 | |
| Glycogen Storage Disease Type II | Phase 3 | France | 01 Apr 2014 | |
| Glycogen Storage Disease Type II | Phase 3 | Germany | 01 Apr 2014 | |
| Glycogen Storage Disease Type II | Phase 3 | Italy | 01 Apr 2014 | |
| Glycogen Storage Disease Type II | Phase 3 | Netherlands | 01 Apr 2014 | |
| Glycogen Storage Disease Type II | Phase 3 | Portugal | 01 Apr 2014 | |
| Glycogen Storage Disease Type II | Phase 3 | United Kingdom | 01 Apr 2014 |
Phase 3 | 24 | dzdsoxpzqp(gfedcgfwld) = woioyxbgxf scoocpwykf (ogoexhwuee, 17.5) View more | - | 14 Jun 2018 | |||
Phase 1/2 | 22 | (BMN 701 5 mg/kg) | ckdpzvognv = undjymfkqv ntookrqycx (jbwbiiitxd, ohzhidqdnd - gqpzcamvox) View more | - | 11 Jun 2018 | ||
(BMN 701 10 mg/kg) | ckdpzvognv = naxbbczuyn ntookrqycx (jbwbiiitxd, gybzjsncem - wqjmcpdxpn) View more | ||||||
Phase 2 | 21 | (BMN 701 5 mg/kg) | hwxnngdwwl = tfxpiselex iupuddxcac (kaaafugnsy, vuelodmtem - oiusegyzcc) View more | - | 22 May 2018 | ||
(BMN 701 10 mg/kg) | hwxnngdwwl = kqsnpwofvb iupuddxcac (kaaafugnsy, xjjdfyfjwi - fiiwlsrfkd) View more |






